BioMarin Statistics, Revenue Totals, Facts & News (2022)
Last Updated on: February 23rd, 2022
Here are a few of the most interesting BioMarin statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
BioMarin Facts
- BioMarin Website: Official Website
- Year BioMarin was Founded: 1997
- BioMarin Headquarters: San Rafael, CA
- BioMarin Founder(s): Christopher Starr and Glen Denison, Jr
- Current BioMarin Chief Executive: Jean-Jacques Bienaime
What is BioMarin?
BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. We remain steadfast to our original mission—to bring new treatments to market that will make a big impact on small patient populations. These patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide. These conditions are often inherited, difficult to diagnose, progressively debilitating, have few, if any, treatment options and are usually ignored. (source)
BioMarin Revenue Totals
BioMarin annual revenue:
- 2019: $1.704 billion
- 2018: $1.491 billion
- 2017: $1.313 billion
- 2016: $1.116 billion
- 2015: $889.9 million
BioMarin annual net income:
- 2019: $23.8 million net loss
- 2018: $77.2 million net loss
- 2017: $117 million net loss
- 2016: $630.2 million net loss
- 2015: $171.8 million net loss
Please note that some of these numbers are easier to find than others. A few of these BioMarin statistics come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.
Related Categories:
Related Tags: